GT BIOPHARMA, INC. Earnings Per Share, Basic and Diluted
GT BIOPHARMA, INC. (GTBP) reported Earnings Per Share, Basic and Diluted of -$2.06 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-28
- GT BIOPHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.17.
- GT BIOPHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.15.
- GT BIOPHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$1.83.
- GT BIOPHARMA, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.64.
- GT BIOPHARMA, INC. earnings per share, basic and diluted for fiscal 2021 was -$2.06.
- GT BIOPHARMA, INC. earnings per share, basic and diluted for fiscal 2020 was -$6.45.
- GT BIOPHARMA, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.01.
- GT BIOPHARMA, INC. earnings per share, basic and diluted for fiscal 2018 was -$5.16.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$2.06 10-K · filed 2022-03-28 | |||||||
| 2021-09-30 | -$0.17 10-Q · filed 2021-11-10 | -$1.54 10-Q · filed 2021-11-10 | ||||||
| 2021-06-30 | -$0.15 10-Q/A · filed 2021-12-29 | -$1.39 10-Q/A · filed 2021-12-29 | ||||||
| 2021-03-31 | -$1.83 10-Q · filed 2021-05-17 | |||||||
| 2020-12-31 | -$6.45 10-K · filed 2022-03-28 | |||||||
| 2020-09-30 | -$0.64 10-Q · filed 2021-11-10 | -$0.04 10-Q · filed 2020-11-13 | -$5.13 10-Q · filed 2021-11-10 | -$0.18 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | -$4.12 10-Q/A · filed 2021-12-29 | -$0.12 10-Q · filed 2020-08-14 | -$4.58 10-Q/A · filed 2021-12-29 | -$0.15 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | -$0.41 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | -$0.01 10-K · filed 2021-04-16 | -$0.67 10-K · filed 2020-03-27 | ||||||
| 2019-09-30 | -$0.51 10-Q · filed 2020-11-13 | -$0.69 10-Q · filed 2020-11-13 | ||||||
| 2019-06-30 | -$0.05 10-Q/A · filed 2020-08-18 | -$0.14 10-Q/A · filed 2020-08-18 | ||||||
| 2018-12-31 | -$5.16 10-K · filed 2020-03-27 | |||||||
| 2018-09-30 | -$4.70 10-Q · filed 2019-11-14 | -$5.09 10-Q · filed 2019-11-14 | ||||||
| 2018-06-30 | -$0.18 10-Q · filed 2019-08-14 | -$0.38 10-Q · filed 2019-08-14 | ||||||
| 2017-12-31 | -$8.60 10-K · filed 2019-03-29 | |||||||
| 2017-09-30 | -$8.15 10-Q · filed 2018-11-14 | -$24.54 10-Q · filed 2018-11-14 | ||||||
| 2017-03-31 | -$26.36 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | $0.86 10-K · filed 2017-03-31 | |||||||
| 2016-03-31 | $0.84 10-Q/A · filed 2018-02-28 | |||||||
| 2015-12-31 | -$8.96 10-K/A · filed 2018-02-28 | -$13.67 10-K · filed 2016-03-30 | ||||||
| 2014-12-31 | -$0.04 10-K/A · filed 2018-02-28 | |||||||
| 2013-12-31 | -$0.01 10-K · filed 2015-03-31 | |||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-12-17 | $0.00 10-Q · filed 2014-12-17 | ||||||
| 2012-12-31 | -$0.01 10-K · filed 2015-01-08 | |||||||
| 2012-09-30 | $0.00 10-Q · filed 2014-12-17 | -$0.01 10-Q · filed 2014-12-17 | ||||||
| 2012-06-30 | -$0.01 10-Q/A · filed 2012-09-13 | -$0.01 10-Q/A · filed 2012-09-13 | ||||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-21 | |||||||
| 2011-12-31 | -$0.02 10-K · filed 2014-11-18 | |||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-21 | -$0.01 10-Q · filed 2012-11-21 | ||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-13 | -$0.02 10-Q/A · filed 2012-09-13 | ||||||
| 2011-03-31 | -$0.01 10-Q · filed 2012-05-21 | |||||||
| 2010-12-31 | -$0.03 10-K · filed 2012-04-16 | |||||||
| 2010-09-30 | $0.01 10-Q · filed 2011-11-21 | -$0.02 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-12 | -$0.02 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |